{
  "abstract": "The Oropouche virus (OROV) is an emerging zoonotic orthobunyavirus responsible for recurring outbreaks of febrile illness and neurological disorders in South and Central America. Despite its growing public health issues, no FDA-approved vaccines or antiviral therapies currently exist. To address this gap, a multiepitope subunit vaccine was designed to target OROV glycoproteins G1 (Gn), G2 (Gc), and the nucleocapsid (N) protein using a reverse-vaccinology (RV) approach. For vaccine construction, suitable epitopes (MHC-I, MHC-II, and linear B-cell) were selected based on percentile rank, antigenicity, allergenicity, and toxicity. However, the biophysical attributes demonstrated advantageous characteristics, including stability and solubility (GRAVY score: −0.432). The structural modelling exhibited a Ramachandran and Z scores of 91.86% (most favoured regions) and −1.81, respectively. However, the molecular docking with TLR-2 and TLR-4 receptors showed probable interactions (−1126.8 kJ/mol) and (−1239.4 kJ/mol), respectively. Moreover, dynamics simulation of the vaccine and Vaccine-TLR-4 complexes confirmed probable dynamic stability and compactness. The codon optimisation for Escherichia coli K12 expression yielded a CAI value of 1.0 and a GC content of (30–70) %, indicating optimal expression. The immune simulation predicted strong antibody-mediated and T cell-mediated immunity, including elevated IFN-γ, IgG, and memory cell populations. These findings suggest the potential of multiepitope subunit vaccines as a promising preventive candidate against OROV. However, additional experimental verification is required to confirm its immunogenicity and safety in experimental settings.",
  "abstract_shown": true,
  "affiliations": [
    "Department of Chemistry, Savitribai Phule Pune University (formerly University of Pune), Pune, India",
    "Department of Microbiology, Notre Dame University Bangladesh (NDUB), Dhaka, Bangladesh"
  ],
  "article_type": "Research Article",
  "arxiv": null,
  "author_total": 2,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Jwel Sharma"
    },
    {
      "affs": [
        1
      ],
      "name": "Ahmad Abdullah Mahdeen"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/35gmx107de99d.bib",
  "cited_by": 0,
  "doi": "10.1371/journal.pone.0360186",
  "fulltext_url": null,
  "id": "35gmx107de99d",
  "issns": [
    "1932-6203"
  ],
  "landing_url": "https://doi.org/10.1371/journal.pone.0360186",
  "language": null,
  "licence": "CC-BY-4.0",
  "licence_label": "CC BY 4.0",
  "licence_source": "journal",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "openalex",
      "1312|vaccines and immunoinformatics approaches"
    ],
    [
      "plos",
      "/Biology and life sciences/Biochemistry/Proteins/Immune system proteins/Antigens"
    ],
    [
      "plos",
      "/Biology and life sciences/Cell biology/Cellular types/Animal cells/Blood cells/White blood cells/B cells"
    ],
    [
      "plos",
      "/Biology and life sciences/Cell biology/Cellular types/Animal cells/Immune cells/Antibody-producing cells/B cells"
    ],
    [
      "plos",
      "/Biology and life sciences/Cell biology/Cellular types/Animal cells/Immune cells/White blood cells/B cells"
    ],
    [
      "plos",
      "/Biology and life sciences/Immunology/Clinical immunology/Allergies"
    ],
    [
      "plos",
      "/Biology and life sciences/Immunology/Immune cells/Antibody-producing cells/B cells"
    ],
    [
      "plos",
      "/Biology and life sciences/Immunology/Immune cells/White blood cells/B cells"
    ],
    [
      "plos",
      "/Biology and life sciences/Immunology/Immune response"
    ],
    [
      "plos",
      "/Biology and life sciences/Immunology/Immune system proteins/Antigens"
    ],
    [
      "plos",
      "/Biology and life sciences/Immunology/Vaccination and immunization"
    ],
    [
      "plos",
      "/Biology and life sciences/Microbiology/Virology/Viral vaccines"
    ],
    [
      "plos",
      "/Biology and life sciences/Physiology/Immune physiology/Antigens"
    ],
    [
      "plos",
      "/Medicine and health sciences/Clinical medicine/Clinical immunology/Allergies"
    ],
    [
      "plos",
      "/Medicine and health sciences/Immunology/Clinical immunology/Allergies"
    ],
    [
      "plos",
      "/Medicine and health sciences/Immunology/Immune cells/Antibody-producing cells/B cells"
    ],
    [
      "plos",
      "/Medicine and health sciences/Immunology/Immune cells/White blood cells/B cells"
    ],
    [
      "plos",
      "/Medicine and health sciences/Immunology/Immune response"
    ],
    [
      "plos",
      "/Medicine and health sciences/Immunology/Immune system proteins/Antigens"
    ],
    [
      "plos",
      "/Medicine and health sciences/Immunology/Vaccination and immunization"
    ],
    [
      "plos",
      "/Medicine and health sciences/Medical conditions/Infectious diseases/Infectious disease control/Vaccines"
    ],
    [
      "plos",
      "/Medicine and health sciences/Medical conditions/Infectious diseases/Infectious disease control/Vaccines/Viral vaccines"
    ],
    [
      "plos",
      "/Medicine and health sciences/Public and occupational health/Preventive medicine/Vaccination and immunization"
    ],
    [
      "plos",
      "/Physical sciences/Physics/Thermodynamics/Free energy"
    ]
  ],
  "openalex": "W7221198245",
  "pdf_url": "https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0360186&type=printable",
  "pmcid": null,
  "pmid": null,
  "published": "2026-10-09",
  "publisher": "Public Library of Science",
  "ris": "https://research.draconitic.com/paper/35gmx107de99d.ris",
  "sources": [
    {
      "first_seen": "2026-10-30T12:17:30Z",
      "native_id": "10.1371/journal.pone.0360186",
      "source": "plos",
      "url": "https://doi.org/10.1371/journal.pone.0360186"
    }
  ],
  "subjects": [
    {
      "field": "biology",
      "origin": "plos:immunology",
      "subfield": "immunology"
    }
  ],
  "title": "An immunoinformatics-driven multiepitope subunit vaccine targeting Oropouche virus: Molecular docking, immune and dynamics simulation approaches",
  "title_text": "An immunoinformatics-driven multiepitope subunit vaccine targeting Oropouche virus: Molecular docking, immune and dynamics simulation approaches",
  "type": "peer-reviewed",
  "updated_at": "2026-10-30T12:17:30Z",
  "url": "https://research.draconitic.com/paper/35gmx107de99d",
  "venue": "PLOS One",
  "versions": []
}